Panel discussion on achieving glycemic control.
This discussion contains excerpts from the satellite symposium, "Achieving Better Glycemic Control Through Management of Mealtime Glucose," presented at the American Association of Clinical Endocrinologists Tenth Annual Meeting and Clinical Congress in San Antonio, Texas, May 2, 2001.
Buse
J B
JB
Scripps Whittier Institute for Diabetes, University of California at San Diego, Diabetes and Endocrine Associates, La Jolla, California, USA.
Einhorn
D
D
D001786:Blood Glucose; D003510:Cyclohexanes / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D000077715:Nateglinide; D010649:Phenylalanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D001786:Blood Glucose; D003510:Cyclohexanes; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D008687:Metformin; D000077715:Nateglinide; D010649:Phenylalanine; D013453:Sulfonylurea Compounds